Lung cancer, long known to affect smokers, is seeing a significant rise in people who do not smoke, said doctors, raising ...

Background Limited research exists on screening thresholds for low-dose CT in detecting malignant pure ground-glass lung ...

Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Muscle Invasive Bladder Cancer (MIBC).

Tevimbra is under clinical development by BeiGene and currently in Phase II for Muscle Invasive Bladder Cancer (MIBC).

In January 2024, the FDA approved erdafitinib (Balversa) for adult patients with locally advanced or metastatic urothelial ...

Invasive carcinoma has spread to nearby tissue ... 67 years old for colorectal cancer, 71 years old for lung cancer, and 66 years old for prostate cancer. All of these are predominantly associated ...

According to the authors of the discovery, their invention may provide a breakthrough in non-invasive lung cancer screening.

Jazz Pharmaceuticals announced that the FDA has approved ZIIHERA® (zanidatamab-hrii) on an accelerated basis for the treatment ...